Bupropion Hydrochloride extended-release tablets (SR), available in 150mg strength, are the generic equivalent of Wellbutrin SR and are indicated for the treatment of major depressive disorder.
Bupropion Hydrochloride extended-release tablets (SR), available in 150mg strength, are the generic equivalent of Zyban and are indicated as an aid to smoking cessation treatment.
Terry Fullem, vice president of marketing and portfolio in US at Actavis, said: “These approvals further enhance our strength in the area of modified release products and provide valuable options to our customers and patients.”